AFI launches call for dementia funding 2026
The Alzheimer Research Initiative e.V. has opened its annual call for funding for research into Alzheimer’s and related dementias. Researchers can submit applications until 30 January 2026 to fund projects in basic research and applied science. The initiative aims to gain new insights into the causes, diagnosis and treatment of dementia in the face of rising case numbers in an ageing society.
Research grants of up to 200,000 euros are available for a maximum period of three years. These are aimed at established scientists and cover topics such as molecular mechanisms, biomarker development or innovative treatment approaches. Early Career Grants of up to 60,000 euros for a maximum of two years are available for young researchers with a doctorate who can prove a suitable scientific environment. These are intended to make it easier to enter independent research and promote young talent.

In addition, AFI supports international cooperation projects with partners from the Netherlands (Alzheimer Nederland), France (Fondation Vaincre Alzheimer) and the USA (Bright Focus Foundation). Up to 200,000 euros are available for two years to form cross-border teams and intensify knowledge exchange. All applications are peer-reviewed by the AFI Scientific Advisory Board and international experts to ensure the highest quality.
The application is made online via www.alzheimer-research.eu with a short application (letter of intent). Access will be activated from January 2, 2026. AFI, a non-profit organization, is financed by donations and has supported over 300 projects with more than 15 million euros since 1995. The current call addresses the urgent need for progress, as around 1.8 million people suffer from dementia in Germany alone, and the trend is rising.
This funding could contribute to breakthroughs in prevention and therapy, for example through new drugs or early diagnostic methods. Interested parties should plan early, as the deadline is tight.
Editor: X-Press Journalistenbüro GbR
Gender Notice. The personal designations used in this text always refer equally to female, male and diverse persons. Double/triple naming and gendered designations are used for better readability. ected.




